|Last Price$0.79||Day Change (%)-5.61%|
|Open Price$0.84||Day Change ($)-0.05|
|Day Range0.77–0.85||52-Week Range0.64–4.07|
As of Fri 8/26/2016 5:00:00 PM | USD
Options on this firm's blockbuster cost a little but pay off big.
Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.
Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...